AI news ·
TRI adds AI risk assessment to its clinical-trial platform
TRI added an AI tool called RiskIQ to its clinical-trial platform that drafts risk assessments, which managers must then review and approve, with all decisions logged.
TRI has added an AI risk-assessment feature to its clinical-trial platform. The new capability, called RiskIQ, is an agent that drafts protocol risk assessments for review by managers.
Managers must edit, accept, or reject each draft assessment. Every decision is retained in an audit log, creating a clear record of human accountability. The design illustrates how generative assistance can support regulated work without bypassing the required review steps.
Source: https://dailyaibrief.com